A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials

A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials

Introduction. One of the more promising developments in preventing the spread of infections, including COVID-19, is the production of vaccines based on virus-like particles (VLP). Currently, in the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry o...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiana V. Grebennikova, Olga N. Zaykova, Alexey A. Plotnikov, Lyudmila V. Kostina, Yana Yu. Chernoryzh, Olesia V. Eliseeva, Oleg E. Latyshev, Viktor F. Larichev, Irina T. Fedyakina, Milana A. Losich, Ilya M. Kirillov, Ilya E. Filatov, Marina V. Balandina, Valery V. Tsibezov, Kirill I. Yurlov, Ekaterina I. Lesnova, Valeria M. Kondratieva, Alina A. Kozlova, Marina S. Baranets, Aleksandr L. Gintsburg
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2025-05-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
covid-19
sars-cov-2
virus-like particles
vlp
Online Access:https://microbiol.crie.ru/jour/article/viewFile/18822/1586
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://microbiol.crie.ru/jour/article/viewFile/18822/1586

Similar Items